Jailed Balloon Technique Is Superior to Jailed Wire Technique in Reducing the Rate of Side Branch Occlusion: Subgroup Analysis of the Conventional Versus Intentional StraTegy in Patients With High Risk PrEdiction of Side Branch OccLusion in Coronary Bifurcation InterVEntion Trial

Dong Zhang, Zhiyong Zhao, Guofeng Gao, Han Xu, Hao Wang, Shuai Liu, Dong Yin, Lei Feng, Chenggang Zhu, Yang Wang, Yanyan Zhao, Yuejin Yang, Runlin Gao, Bo Xu, Kefei Dou, Dong Zhang, Zhiyong Zhao, Guofeng Gao, Han Xu, Hao Wang, Shuai Liu, Dong Yin, Lei Feng, Chenggang Zhu, Yang Wang, Yanyan Zhao, Yuejin Yang, Runlin Gao, Bo Xu, Kefei Dou

Abstract

Objective: Jailed balloon technique (JBT) is an active side branch (SB) protection strategy and is considered to be superior to the jailed wire technique (JWT) in reducing SB occlusion. However, no randomized trials have proved that. We aim to investigate whether JBT could decrease the SB occlusion rate.

Methods: Conventional versus Intentional straTegy in patients with high Risk prEdiction of Side branch OccLusion in coronary bifurcation interVEntion (CIT-RESOLVE) (NCT02644434, registered on December 31, 2015) (https://clinicaltrials.gov) is a randomized trial that assessed the effects of different strategies on SB occlusion rate in patients with a high risk of SB occlusion. The present subgroup analysis enrolled bifurcation lesions (2 mm ≤ reference vessel diameter of SB < 2.5 mm) with Visual estimation for Risk prEdiction of Side branch OccLusion in coronary bifurcation intervention (V-RESOLVE) score ≥ 12 points. The primary endpoint is SB occlusion. One-year clinical events were compared.

Results: A total of 284 subjects at 16 sites were randomly assigned to the JBT group (n = 143) or the JWT group (n = 141). The rate of SB occlusion (9.1 vs. 19.9%, p = 0.02) and periprocedural myocardial infarction (defined by WHO, 7 vs. 14.9%, p = 0.03) is significantly lower in the JBT group than in the JWT group. The JBT and JWT groups showed no significant differences in cardiac death (0.7 vs. 0.7%, p = 1), myocardial infarction (MI, 6.3 vs. 7.1%, p = 0.79), target lesion revascularization (TLR, 1.4 vs. 2.1%, p = 0.68), and major cardiac adverse events (MACE, a composite of all-cause death, MI, or TLR, 8.4 vs. 10.6%, p = 0.52) during a 1-year follow-up.

Conclusion: In patients with a high risk of SB occlusion (V-RESOLVE score ≥ 12 points), JBT is superior to JWT in reducing SB occlusion. However, no significant differences were detected in 1-year MACE.

Keywords: coronary bifurcation lesions; jailed balloon technique; jailed wire technique; major adverse cardiac event (MACE); side branch occlusion.

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Copyright © 2022 Zhang, Zhao, Gao, Xu, Wang, Liu, Yin, Feng, Zhu, Wang, Zhao, Yang, Gao, Xu and Dou.

Figures

FIGURE 1
FIGURE 1
Study population. From December 2016 to April 2019, a total of 335 subjects were randomly assigned to the active strategy group (n = 168) or conventional strategy group (n = 167). Among them, 143 patients in the active strategy group have an SB with 2 mm ≤ RVD < 2.5 mm and were assigned to JBT accordingly, while 141 patients in the conventional strategy group have an SB with 2 mm ≤ RVD < 2.5 mm and were assigned to JWT. For the ATS, 140 patients underwent the JBT strategy and 138 patients underwent the JWT strategy. IC, informed content; JBT, jailed balloon technique; JWT, jailed wire technique; ITT, intention to treat; ATS, as treated set.
FIGURE 2
FIGURE 2
The incidence of the primary endpoint [side branch (SB) occlusion] and its 2 components [TIMI (thrombolysis in myocardial infarction) flow grade decrease and absence of blood flow] between the SB protection jailed balloon technique (JBT) group and jailed wire technique (JWT) group. CI, confidence interval.
FIGURE 3
FIGURE 3
MACE-free survival rate at 1 year. The rate was 91.6% in the JBT group, and it was 89.4% in the JWT group (p = 0.52). MACE: major adverse cardiac event; JBT: jailed balloon technique; JWT: jailed wire technique.

References

    1. Muramatsu T, Onuma Y, Garcia-Garcia HM, Farooq V, Bourantas CV, Morel MA, et al. Incidence and short-term clinical outcomes of small side branch occlusion after implantation of an everolimus-eluting bioresorbable vascular scaffold: an interim report of 435 patients in the absorb-extend single-arm trial in comparison with an everolimus-eluting metallic stent in the spirit first and ii trials. JACC Cardiovasc Interv. (2013) 6:247–57. 10.1016/j.jcin.2012.10.013
    1. Hahn JY, Chun WJ, Kim JH, Song YB, Oh JH, Koo BK, et al. Predictors and outcomes of side branch occlusion after main vessel stenting in coronary bifurcation lesions: results from the COBIS II registry (coronary bifurcation stenting). J Am Coll Cardiol. (2013) 62:1654–9. 10.1016/j.jacc.2013.07.041
    1. Banning AP, Lassen JF, Burzotta F, Lefevre T, Darremont O, Hildick-Smith D, et al. Percutaneous coronary intervention for obstructive bifurcation lesions: the 14th consensus document from the European bifurcation club. EuroIntervention. (2019) 15:90–8. 10.4244/EIJ-D-19-00144
    1. Neumann FJ, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U, et al. 2018 ESC/EACTS guidelines on myocardial revascularization. Eur Heart J. (2019) 40:87–165. 10.1093/eurheartj/ehy394
    1. Sawaya FJ, Lefevre T, Chevalier B, Garot P, Hovasse T, Morice MC, et al. Contemporary approach to coronary bifurcation lesion treatment. JACC Cardiovasc Interv. (2016) 9:1861–78. 10.1016/j.jcin.2016.06.056
    1. Burzotta F, Trani C, Sianos G. Jailed balloon protection: a new technique to avoid acute side-branch occlusion during provisional stenting of bifurcated lesions. bench test report and first clinical experience. EuroIntervention. (2010) 5:809–13. 10.4244/eijv5i7a135
    1. Zhang D, Yin D, Song C, Zhu C, Kirtane AJ, Xu B, et al. A randomised comparison of conventional versus intentional strategy in patients with high risk prediction of side branch occlusion in coronary bifurcation intervention: rationale and design of the cit-resolve trial. BMJ Open. (2017) 7:e016044. 10.1136/bmjopen-2017-016044
    1. Dou K, Zhang D, Pan H, Guo N, Li L, Li Y, et al. Active SB-P versus conventional approach to the protection of high-risk side branches: the CIT-RESOLVE trial. JACC Cardiovasc Interv. (2020) 13:1112–22. 10.1016/j.jcin.2020.01.233
    1. Singh J, Patel Y, Depta JP, Mathews SJ, Cyrus T, Zajarias A, et al. A modified provisional stenting approach to coronary bifurcation lesions: clinical application of the “jailed-balloon technique”. J Interv Cardiol. (2012) 25:289–96. 10.1111/j.1540-8183.2011.00716.x
    1. Moussa ID, Klein LW, Shah B, Mehran R, Mack MJ, Brilakis ES, et al. Consideration of a new definition of clinically relevant myocardial infarction after coronary revascularization: an expert consensus document from the society for cardiovascular angiography and interventions (SCAI). J Am Coll Cardiol. (2013) 62:1563–70. 10.1016/j.jacc.2013.08.720
    1. Nomenclature and Criteria for Diagnosis of Ischemic Heart Disease. Report of the joint international society and federation of cardiology/World health organization task force on standardization of clinical nomenclature. Circulation. (1979) 59:607–9. 10.1161/01.cir.59.3.607
    1. Garcia-Garcia HM, McFadden EP, Farb A, Mehran R, Stone GW, Spertus J, et al. Standardized end point definitions for coronary intervention trials: the academic research consortium-2 consensus document. Circulation. (2018) 137:2635–50. 10.1161/CIRCULATIONAHA.117.029289
    1. Latib A, Colombo A. Bifurcation disease: what do we know, what should we do? JACC Cardiovasc Interv. (2008) 1:218–26. 10.1016/j.jcin.2007.12.008
    1. Ford TJ, McCartney P, Corcoran D, Collison D, Hennigan B, McEntegart M, et al. Single- versus 2-stent strategies for coronary bifurcation lesions: a systematic review and meta-analysis of randomized trials with long-term follow-up. J Am Heart Assoc. (2018) 7:e008730. 10.1161/JAHA.118.008730
    1. Saito S, Shishido K, Moriyama N, Ochiai T, Mizuno S, Yamanaka F, et al. Modified jailed balloon technique for bifurcation lesions. Cathet Cardiovasc Interv. (2018) 92:E218–26. 10.1002/ccd.27334
    1. Shishido K, Moriyama N, Hayashi T, Yokota S, Miyashita H, Mashimo Y, et al. The efficacy of modified jailed balloon technique for true bifurcation lesions. Cathet Cardiovasc Interv. (2020) 96:20–8. 10.1002/ccd.28812
    1. Numasawa Y, Hitomi Y, Imaeda S, Yokokura S, Tanaka M, Tabei R, et al. Stent deformation caused by entrapment of the side branch balloon catheter during the jailed balloon protection technique for a calcified coronary bifurcation lesion: a case report and literature review. Cardiovasc Revasc Med. (2019) 20:1023–6. 10.1016/j.carrev.2018.11.003
    1. Jang JS, Jin HY, Seo JS, Yang TH, Kim DK, Kim DS, et al. Prognostic value of creatine kinase-myocardial band isoenzyme elevation following percutaneous coronary intervention: a meta-analysis. Cathet Cardiovasc Interv. (2013) 81:959–67. 10.1002/ccd.24542
    1. Kong TQ, Davidson CJ, Meyers SN, Tauke JT, Parker MA, Bonow RO. Prognostic implication of creatine kinase elevation following elective coronary artery interventions. JAMA. (1997) 277:461–6. 10.1001/jama.1997.03540300029029
    1. Akkerhuis KM, Alexander JH, Tardiff BE, Boersma E, Harrington RA, Lincoff AM, et al. Minor myocardial damage and prognosis: are spontaneous and percutaneous coronary intervention-related events different? Circulation. (2002) 105:554–6. 10.1161/hc0502.104278
    1. Ioannidis JP, Karvouni E, Katritsis DG. Mortality risk conferred by small elevations of creatine kinase-MB isoenzyme after percutaneous coronary intervention. J Am Coll Cardiol. (2003) 42:1406–11. 10.1016/s0735-1097(03)01044-1

Source: PubMed

3
Abonner